What type of study is this?

December 8, 2025BloodOpen Access

Optimization of stem cell fitness and mobilization using moderate transfusion and an oral anti-sickling agent in the sickle mouse model.

View Full Paper

Ask AI

Bookmark

Authors

JWJon WadeUniversity of Oxford APAshwin PatelEmory University LWLawrence J. WilsonEmory University

Discussion

Member takes

Implication

Observational analysis improved hematopoietic stem cell mobilization and fitness in a sickle cell mouse model, suggesting alternatives to transfusion therapy.

Key Points

Anemia was improved through disease modification with osivelotor, enhancing HSC fitness and mobilization.
Osivelotor-treated mice exhibited a 1.33-fold higher efficiency in engraftment of HSCs compared to untreated controls.
Chronic transfusion therapy showed significant engraftment rates at 100% compared to 67% in controls, indicating its effectiveness.
Switching to non-myelosuppressive agents like osivelotor may provide safer alternatives to traditional transfusion protocols.

Cite This Study

Wade et al. (2025) studied this question.

synapsesocial.com/papers/69362f7d4fa91c937236e48b https://doi.org/10.1182/blood-2025-1150

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis improved hematopoietic stem cell mobilization and fitness in a sickle cell mouse model, suggesting alternatives to transfusion therapy.

Optimization of stem cell fitness and mobilization using moderate transfusion and an oral anti-sickling agent in the sickle mouse model.

Discussion

Member takes

Implication

Key Points

Cite This Study

Optimization of stem cell fitness and mobilization using moderate transfusion and an oral anti-sickling agent in the sickle mouse model.

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider